Movement Alert|ASML Rises 3.42% in Pre-Market Trading, RBC Raises Target Price to $2000 Citing Strong EUV Demand Outlook

Market Focus
Jul 14

On July 14, ASML rose 3.42% in pre-market trading, trading at approximately $1792.86/share, with turnover of $48.97 million.

On the news front, RBC Capital Markets raised its price target on ASML from $1700 to $2000, maintaining an Outperform rating. RBC highlighted that EUV demand remains robust, driven by generative AI investment, tight DRAM supply, and intensifying competition among leading-edge foundry customers, with supply tightness likely to persist for two to three years. The brokerage also raised its 2027 EUV shipment forecast to approximately 90 low-NA systems from a prior estimate of over 80 units, expecting demand to exceed 90 units in both 2027 and 2028.

The broader semiconductor equipment sector rallied in tandem, with Applied Materials up 7.02%, Lam Research up 6.84%, KLA-Tencor up 6.64%, and Teradyne up 6.12%. ASML is scheduled to report Q2 earnings on July 15 before market open, with consensus expecting revenue of approximately 88.3 billion euros. Multiple institutions anticipate the company may raise full-year sales guidance for the second time this year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10